Wells Fargo analyst Stephen Baxter lowered the firm’s price target on Cigna (CI) to $341 from $370 and keeps an Equal Weight rating on the shares. The firm notes Stop Loss pressure was digested quickly, with shares underperforming only modestly since reporting Q4. In Wells’ view, this leaves risk/reward generally balanced in light of weak Q4 fundamentals and ongoing PBM uncertainty.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CI:
